We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
CALL
Tesla
TSLA
$1.3T
| $26.3M | 0.02% |
58,500
+8,800
| +18% | +$3.9M |
|
527
Rigel Pharmaceuticals
RIGL
$750M
| $26.3M | 0.02% |
613,600
+12,267
| +2% | +$462K |
|
|
Q
528
Qnity Electronics Inc
Q
$28.9B
| $26.2M | 0.02% |
+321,435
| New | +$27.3M |
|
529
Beam Therapeutics
BEAM
$2.84B
| $26.2M | 0.02% |
+945,829
| New | +$24.1M |
|
530
Zebra Technologies
ZBRA
$17.8B
| $26.1M | 0.02% |
+107,603
| New | +$28.8M |
|
531
United Parcel Service
UPS
$88.9B
| $26.1M | 0.02% |
263,319
-9,392
| -3% | -$879K |
|
532
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$40.9B
| $26.1M | 0.02% |
299,000
-43,800
| -13% | -$3.92M |
|
533
SharkNinja
SN
$26.1B
| $26M | 0.02% |
232,165
+118,339
| +104% | +$11.7M |
|
534
Graphic Packaging
GPK
$3.58B
| $25.6M | 0.02% |
1,698,742
+1,333,800
| +365% | +$21.9M |
|
535
Dentsply Sirona
XRAY
$2.43B
| $25.6M | 0.02% |
2,236,786
+2,039,280
| +1,033% | +$23.9M |
|
536
Nike
NKE
$61.9B
| $25.5M | 0.02% |
+399,708
| New | +$26.1M |
|
537
HubSpot
HUBS
$10.5B
| $25.4M | 0.02% |
63,356
-716
| -1% | -$297K |
|
538
Medpace
MEDP
$16.5B
| $25.2M | 0.02% |
44,951
+38,359
| +582% | +$21.8M |
|
539
Aurinia Pharmaceuticals
AUPH
$2.11B
| $25.1M | 0.02% |
1,574,957
+91,825
| +6% | +$1.3M |
|
540
AMC Entertainment Holdings
AMC
$2.31B
| $25.1M | 0.02% |
16,068,266
+3,252,198
| +25% | +$7.76M |
|
|
APLS
541
DELISTED
Apellis Pharmaceuticals
APLS
| $24.9M | 0.02% |
990,848
+594,113
| +150% | +$13.9M |
|
542
Ameriprise Financial
AMP
$48.8B
| $24.9M | 0.02% |
50,754
-94,204
| -65% | -$44.7M |
|
543
Charles River Laboratories
CRL
$12.8B
| $24.8M | 0.02% |
124,193
-13,917
| -10% | -$2.52M |
|
544
BioNTech
BNTX
$23.5B
| $24.8M | 0.02% |
260,107
+256,562
| +7,237% | +$25.8M |
|
545
Urban Outfitters
URBN
$6.59B
| $24.7M | 0.02% |
328,581
-85,881
| -21% | -$6.08M |
|
546
EastGroup Properties
EGP
$10.9B
| $24.5M | 0.02% |
137,671
-17,242
| -11% | -$3.07M |
|
547
Grocery Outlet
GO
$980M
| $24.5M | 0.02% |
2,426,062
-2,151,309
| -47% | -$27.1M |
|
548
WD-40
WDFC
$3.15B
| $24.5M | 0.02% |
124,410
-17,106
| -12% | -$3.37M |
|
549
MaxLinear
MXL
$6.8B
| $24.4M | 0.02% |
1,402,556
-423,703
| -23% | -$6.9M |
|
550
Frontdoor
FTDR
$6.26B
| $24.4M | 0.02% |
422,381
+67,627
| +19% | +$3.98M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.